Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 7, 2026

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
10:37

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

Published on: August 22, 2025

[The multifocal breast cancer].

E L Kirillova, S V Odintsov, E I Brekhov

    Khirurgiia
    |October 1, 2013
    PubMed
    Summary
    This summary is machine-generated.

    Organ-preserving surgery for multifocal breast cancer (stages I-II) with adjuvant therapy shows survival rates comparable to mastectomy. This approach maintains 5 and 10-year survival and recurrence-free rates.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    DIAGNOSTIC AND TACTICAL IMPORTANCE OF STUDYING SHORT CHAIN FATTY ACIDS IN DIFFERENT BIOLOGICAL SUBSTRATES TOOK PLACE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, LUNG CANCER AND COMMUNITY-ACQUIRED PNEUMONIA DEVELOPED AFTER ANTICANCER THERAPY.

    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology·2018
    Same author

    [Results of dynamic observation of patients with polyps in the stomach].

    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology·2014
    Same author

    [An 18-year follow-up of a patient with four asynchronous malignant tumors of the urogenital system].

    Urologiia (Moscow, Russia : 1999)·2014
    Same author

    [Diagnostics of the primary multiple forms of the colorectal cancer].

    Khirurgiia·2013
    Same author

    [The substantiation of the method of gastrointestinal reconstruction after the gastric resection].

    Khirurgiia·2013
    Same author

    [Clinical value of antracycline toxicity: modern approaches to diagnosis, prevention, and treatment].

    Kardiologiia·2011

    Area of Science:

    • Oncology
    • Surgical Oncology
    • Breast Cancer Research

    Background:

    • Multifocal breast cancer presents unique surgical challenges.
    • Assessing the impact of surgical resection volume on patient survival is crucial.
    • Organ-preserving techniques are increasingly explored as alternatives to mastectomy.

    Purpose of the Study:

    • To compare survival outcomes between different surgical resection volumes in multifocal breast cancer.
    • To evaluate the efficacy of organ-preserving surgery combined with adjuvant therapy.
    • To determine the impact on overall and recurrence-free survival rates.

    Main Methods:

    • Retrospective analysis of survival data from patients with multifocal breast cancer.
    • Comparison of outcomes following modified radical mastectomy (Madden) and radical mammary gland resection.

    Related Experiment Videos

    Last Updated: May 7, 2026

    A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
    10:37

    A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

    Published on: August 22, 2025

  • Inclusion of patients receiving complex adjuvant therapy.

    • Main Results:

    • Organ-preserving surgery did not result in decreased 5 or 10-year overall survival rates.
    • Recurrence-free survival rates were not negatively impacted by organ-preserving procedures.
    • Outcomes were analyzed in relation to surgical resection volume.

    Conclusions:

    • Organ-preserving surgery is a viable option for multifocal breast cancer stages I-II.
    • Combined with adjuvant therapy, it offers comparable survival to mastectomy.
    • Surgical resection volume does not appear to compromise long-term survival in this context.